🔎 Trials Near Me

Home › Kanser sa Prostate › District of Columbia

Pag-aaral pangklinika para sa Kanser sa Prostate sa District of Columbia

18 pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa mga site sa District of Columbia.

Mga Lungsod sa District of Columbia

Opisyal na teksto ng pag-aaral (English)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Okt 2, 2026 · NCT06931340

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • MedStar Georgetown University Hospital, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06136650

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • Washington DC VA Medical Center, Washington, DC, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • The GW Medical Faculty Associates ( Site 0057), Washington D.C.
  • Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 17, 2026 · NCT06925737

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • George Washington University Medical Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 10, 2026 · NCT05946213

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

  • Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Ago 20, 2026 · NCT07644598

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Sibley Memorial Hospital, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Ago 19, 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Sibley Memorial Hospital, Washington D.C.
  • George Washington University Medical Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Hul 14, 2026 · NCT06592924

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • VA Medical Center, Washington D.C.
Nagre-recruitPhase 4
Edad 18 hanggang 100 · Kalalakihan · Na-update Hun 4, 2026 · NCT05803941

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

  • Cancer Support Community Research & Training Institute, Washington D.C.
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 23, 2026 · NCT02333604

Clinical Trial of Approaches to Prostate Cancer Surgery

  • Georgetown University, Washington D.C.
Nagre-recruit
Edad 40 hanggang 80 · Kalalakihan · Na-update Abr 22, 2026 · NCT05155501

Castrate Resistant Prostate Cancer Enhertu Therapy

  • Washington DC VAMC, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Kalalakihan · Na-update Abr 13, 2026 · NCT06610825

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  • Washington DC VA Medical Center, Washington, DC, Washington D.C.
Nagre-recruitPhase 2/3
Edad 18 pataas · Kalalakihan · Na-update Abr 8, 2026 · NCT04787744

Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer

  • Howard University Hospital, Washington D.C.
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 69 · Kalalakihan · Na-update Nob 10, 2025 · NCT06398639

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • George Washington University Medical Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Kalalakihan · Na-update Set 11, 2025 · NCT03678025

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.